Variant report
Variant | esv3528386 |
---|---|
Chromosome Location | chr5:1923877-1926200 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:6)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:6 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr5:1914837..1916818-chr5:1921898..1924195,2 | K562 | blood: | |
2 | chr5:1923598..1926065-chr5:2006441..2007973,2 | K562 | blood: | |
3 | chr5:1920038..1922611-chr5:1924901..1927373,2 | MCF-7 | breast: | |
4 | chr5:1922868..1925557-chr5:1925659..1927215,2 | MCF-7 | breast: | |
5 | chr5:1922868..1925557-chr5:1925659..1927215,2 | MCF-7 | breast: | |
6 | chr5:1923560..1925350-chr5:1937042..1939475,2 | MCF-7 | breast: |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs541587498 | chr5:1923878-1923879 | Enhancers Bivalent/Poised TSS | n/a | n/a | Overlapped CNVs | n/a |
2 | rs386684497 | chr5:1923912-1923913 | Enhancers Bivalent/Poised TSS | n/a | n/a | Overlapped CNVs | n/a |
3 | rs113810505 | chr5:1923913-1923914 | Enhancers Bivalent/Poised TSS | n/a | n/a | Overlapped CNVs | n/a |
4 | rs6865822 | chr5:1923914-1923915 | Enhancers Bivalent/Poised TSS | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
5 | rs6881134 | chr5:1923961-1923962 | Enhancers Bivalent/Poised TSS | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
6 | rs149281778 | chr5:1923983-1923984 | Enhancers Bivalent/Poised TSS | n/a | n/a | Overlapped CNVs | n/a |
7 | rs144540600 | chr5:1924018-1924019 | Enhancers Bivalent/Poised TSS | n/a | n/a | Overlapped CNVs | n/a |
8 | rs546853777 | chr5:1924042-1924043 | Enhancers Bivalent/Poised TSS | n/a | n/a | Overlapped CNVs | n/a |
9 | rs568597333 | chr5:1924048-1924049 | Enhancers Bivalent/Poised TSS | n/a | n/a | Overlapped CNVs | n/a |
10 | rs73732364 | chr5:1924058-1924059 | Enhancers Bivalent/Poised TSS | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
11 | rs550844804 | chr5:1924076-1924077 | Enhancers Bivalent/Poised TSS | n/a | n/a | Overlapped CNVs | n/a |
12 | rs6880206 | chr5:1924088-1924089 | Enhancers Bivalent/Poised TSS | n/a | n/a | Overlapped CNVs | n/a |
13 | rs367754817 | chr5:1924096-1924097 | Enhancers Bivalent/Poised TSS | n/a | n/a | Overlapped CNVs | n/a |
14 | rs182677956 | chr5:1924107-1924108 | Enhancers Bivalent/Poised TSS | n/a | n/a | Overlapped CNVs | n/a |
15 | rs35521830 | chr5:1924114-1924115 | Enhancers Bivalent/Poised TSS | n/a | n/a | Overlapped CNVs | n/a |
16 | rs73732366 | chr5:1924130-1924131 | Enhancers Bivalent/Poised TSS | n/a | n/a | Overlapped CNVs | n/a |
17 | rs534932373 | chr5:1924137-1924138 | Enhancers Bivalent/Poised TSS | n/a | n/a | Overlapped CNVs | n/a |
18 | rs116482816 | chr5:1924140-1924141 | Enhancers Bivalent/Poised TSS | n/a | n/a | Overlapped CNVs | n/a |
19 | rs531479894 | chr5:1924155-1924156 | Enhancers Bivalent/Poised TSS | n/a | n/a | Overlapped CNVs | n/a |
20 | rs188865666 | chr5:1924156-1924157 | Enhancers Bivalent/Poised TSS | n/a | n/a | Overlapped CNVs | n/a |
21 | rs556837199 | chr5:1924169-1924170 | Enhancers Bivalent/Poised TSS | n/a | n/a | Overlapped CNVs | n/a |
22 | rs574995887 | chr5:1924173-1924174 | Enhancers Bivalent/Poised TSS | n/a | n/a | Overlapped CNVs | n/a |
23 | rs371571301 | chr5:1924181-1924182 | Enhancers Bivalent/Poised TSS | n/a | n/a | Overlapped CNVs | n/a |
24 | rs368277181 | chr5:1924206-1924207 | Enhancers Weak transcription Bivalent/Poised TSS | n/a | n/a | Overlapped CNVs | n/a |
25 | rs141746412 | chr5:1924207-1924208 | Enhancers Weak transcription Bivalent/Poised TSS | n/a | n/a | Overlapped CNVs | n/a |
26 | rs115898725 | chr5:1924247-1924248 | Enhancers Weak transcription Bivalent/Poised TSS | n/a | n/a | Overlapped CNVs | n/a |
27 | rs540600130 | chr5:1924304-1924305 | Enhancers Weak transcription Bivalent/Poised TSS | n/a | n/a | Overlapped CNVs | n/a |
28 | rs147210024 | chr5:1924359-1924360 | Enhancers Weak transcription Bivalent/Poised TSS | n/a | n/a | Overlapped CNVs | n/a |
29 | rs554297425 | chr5:1924435-1924436 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
30 | rs529506670 | chr5:1924438-1924439 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
31 | rs548782191 | chr5:1924457-1924458 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
32 | rs551167517 | chr5:1924496-1924497 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
33 | rs72706744 | chr5:1924522-1924523 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
34 | rs533487184 | chr5:1924523-1924524 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
35 | rs551865707 | chr5:1924541-1924542 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
36 | rs4975766 | chr5:1924549-1924550 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
37 | rs549893983 | chr5:1924581-1924582 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
38 | rs144720927 | chr5:1924591-1924592 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
39 | rs534180338 | chr5:1924592-1924593 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
40 | rs553031743 | chr5:1924593-1924594 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
41 | rs568353367 | chr5:1924828-1924829 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
42 | rs140621942 | chr5:1924970-1924971 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
43 | rs552546023 | chr5:1925011-1925012 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs10036227 | chr5:1925013-1925014 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
45 | rs571133667 | chr5:1925041-1925042 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs537043190 | chr5:1925044-1925045 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
47 | rs540735595 | chr5:1925193-1925194 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
48 | rs113032132 | chr5:1925201-1925202 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
49 | rs111316690 | chr5:1925202-1925203 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs4478361 | chr5:1925303-1925304 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
Disease | PMID | Source |
---|---|---|
Biliary cancer | 19435499 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Breast cancer | 16608533 | CNVD |
Cervical cancer | 16585170 | CNVD |
Glioblastoma multiforme | 22286061 | CNVD |
Lung cancer | 17925434 | CNVD |
Ovarian cancer | 20844748 | CNVD |
Cervical squamous cell carcinoma | 21590768 | CNVD |
Non-small cell lung cancer | 21829676 | CNVD |
Intracranial ependymoma | 16609018 | CNVD |
Breast cancer | 19181860 | CNVD |
prenatal diagnosis | 20453657 | CNVD |
Developmental delay | 19490664 | CNVD |
Human papillomavirus | 17975027 | CNVD |
Acute monocytic leukemia | 16498392 | CNVD |
Gastric cancer | 16891809 | CNVD |
Intracranial aneurysm | 16715129 | CNVD |
Emphysema | 19352772 | CNVD |
Chordoma | 18071362 | CNVD |
Esophageal squamous carcinoma | 18405350 | CNVD |
Lung cancer | 21911935 | CNVD |
Cri-du chat syndrome | 21549014 | CNVD |
Melanoma | 18172304 | CNVD |
Non-syndromic sensorineural hearing loss | 20606397 | CNVD |
Sudden cardiac death | 19188705 | CNVD |
renal disease | 17924346 | CNVD |
abnormal development | 18461090 | CNVD |
Lung cancer | 19547694 | CNVD |
Cri-du chat syndrome | 22283845 | CNVD |
Disorders of sex development | 21048976 | CNVD |
Non-small cell lung cancer | 20864512 | CNVD |
Cancer | 21183584 | CNVD |
Honadal dysgenesis | 21048976 | CNVD |
Cancer | 16751803 | CNVD |
Breast cancer | 17133270 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Salivary gland tumor | 18059337 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Kartagener syndrome | 16639409 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Myofibroblastic sarcoma | 19369631 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Medulloblastoma | 16783165 | CNVD |
Thyroid cancer | 19087340 | CNVD |
Liposarcoma | 21253554 | CNVD |
Pancreatic endocrine tumor | 17639061 | CNVD |
Cervical Cancer | 21857958 | CNVD |
Cervical cancer | 21062161 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Oral cancer | 21386901 | CNVD |
Astrocytoma | 17387387 | CNVD |
Breast cancer | 21264507 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Esophageal squamous carcinoma | 18350619 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Malignant mesothelioma | 18160781 | CNVD |
Pleural malignant mesothelioma | 18160781 | CNVD |
Cervical cancer | 18559093 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Acute lymphoblastic leukemia | 17690704 | CNVD |
Gastrointestinal stromal cancer | 16982739 | CNVD |
Phyllodes tumor | 17334353 | CNVD |
Malaria | 21533027 | CNVD |
Renal cell carcinoma | 19461508 | CNVD |
Colorectal cancer | 21645411 | CNVD |
Gastric cancer | 22152101 | CNVD |
Oesophago-gastric ulcer | 22152101 | CNVD |
Ovarian cancer | 21781307 | CNVD |
T-cell prolymphocytic leukemia | 17713554 | CNVD |
Breast cancer | 20668451 | CNVD |
Cancer | 20668451 | CNVD |
Lung cancer | 20668451 | CNVD |
Ovarian cancer | 20668451 | CNVD |
Pancreas cancer | 20668451 | CNVD |
Prostate cancer | 20668451 | CNVD |
Breast cancer | 21364760 | CNVD |
Cancer | 20164919 | CNVD |
Oral cancer | 22144094 | CNVD |
Non-syndromic sensorineural hearing loss | 18496225 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
low-grade B-cell lymphoma tumor | 18367492 | CNVD |
Multiple myeloma | 17550852 | CNVD |
Pleomorphic liposarcoma | 18784837 | CNVD |
Developmental delay | 21147756 | CNVD |
prenatal diagnosis | 22389664 | CNVD |
Bladder cancer | 21909424 | CNVD |
DNA damage stimulus | 22844521 | CNVD |
DNA repair | 22844521 | CNVD |
Breast cancer | 21785460 | CNVD |
Spinal muscular atrophy | 22422766 | CNVD |
Spinal muscular atrophy | 22558076 | CNVD |
Spinal muscular atrophy | 21320981 | CNVD |
Spinal muscular atrophy | 21762474 | CNVD |
Breast cancer | 21858162 | CNVD |
Prostate cancer | 18632612 | CNVD |
Esophageal adenocarcinoma | 19417022 | CNVD |
Melanoma | 22183965 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Lung cancer | 18438408 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Autism | 22495311 | CNVD |
Gastrointestinal stromal cancer | 20818650 | CNVD |
Schizophrenia | 23813976 | CNVD |
Ependymoma | 20639864 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr5:1923600-1924400 | Bivalent/Poised TSS | Hela-S3 | cervix |
2 | chr5:1923800-1924000 | Enhancers | ES-UCSF4 Cell Line | embryonic stem cell |
3 | chr5:1923800-1924400 | Enhancers | iPS DF 19.11 Cell Line | embryonic stem cell |
4 | chr5:1924200-1928000 | Weak transcription | ES-UCSF4 Cell Line | embryonic stem cell |
5 | chr5:1924400-1925600 | Weak transcription | iPS DF 19.11 Cell Line | embryonic stem cell |
6 | chr5:1925600-1926400 | ZNF genes & repeats | Right Atrium | heart |
7 | chr5:1925600-1927600 | Enhancers | iPS DF 19.11 Cell Line | embryonic stem cell |
8 | chr5:1925800-1926400 | Bivalent Enhancer | Fetal Muscle Trunk | muscle |
9 | chr5:1926000-1926200 | Enhancers | Breast Myoepithelial Primary Cells | Breast |
10 | chr5:1926200-1929200 | Weak transcription | Breast Myoepithelial Primary Cells | Breast |